Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Erectile Dysfunction
NCT02916693Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mirabegron in erectile dysfunction (ED), sponsored by Johns Hopkins University. Primary endpoint: Erectile Function Assessed by International Index of Erectile Function Questionnaire at 12 weeks. Started Aug 2017; status: completed.
02
Drugs
mirabegron
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02916693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02916693.